Evaluation of a tissue-engineered bovine pericardial patch in paediatric patients with congenital cardiac anomalies: Initial experience with the ADAPT-treated CardioCel® patch

Interactive Cardiovascular and Thoracic Surgery

Volumn 17, Issue 4, 2013, Pages 698-702

  Neethling, William M L ^a,b,c   Strange, Geoff ^d   Firth, Laura ^a   Smit, Francis E ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c UNIVERSITY OF THE FREE STATE   (South Africa)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Bovine; Pericardium; Tissue engineered; Xenograft

Indexed keywords

ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; BIOCOMPATIBILITY; BOVINE PERICARDIAL PATCH; CHILD; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMORBIDITY; CONGENITAL HEART MALFORMATION; CORONARY HEMODYNAMICS; DEATH; DEVICE SAFETY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE SEPTUM DEFECT; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFANT; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL PATCH; PEROPERATIVE COMPLICATION; POST TREATMENT SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SURGICAL RISK; SURVIVAL RATE; THROMBOGENICITY;

BOVINE; PERICARDIUM; TISSUE-ENGINEERED; XENOGRAFT;

ADOLESCENT; ANIMALS; CARDIAC SURGICAL PROCEDURES; CATTLE; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HETEROGRAFTS; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; PERICARDIUM; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SOUTH AFRICA; TIME FACTORS; TISSUE ENGINEERING; TREATMENT OUTCOME;

EID: 84885016064     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivt268     Document Type: Article

References (18)

1. Us MH, Sungun M, Sanioglu S, Pocan S, Cebeci BS, Ogus T et al. A retrospective comparison of bovine pericardium and polytetrafluoroethylene patch for closure of ventricular septal defects. J Int Med Res 2004;32: 218-21.
2. Komeda M, Fremes SE, David TE. Surgical repair of postinfarction ventricular septal defect. Circulation 1990;82(5 Suppl):IV243-7.
3. Odim J, Laks H, Allada V, Child J, Wilson S, Gjertson D. Results of aortic valve-sparing and restoration with autologous pericardial leaflet extensions in congenital heart disease. Ann Thorac Surg 2005;80:647-53; discussion 53-4.
4. Schoof PH, Hazekamp MG, van Ulzen K, Bartelings MM, Bruyn JA, Helbing W et al. Autologous pericardium for ventricular septal defect closure. J Heart Valve Dis 1998;7:407-9.
5. Ionescu MI, Tandon AP, Mary DA, Abid A. Heart valve replacement with the Ionescu-Shiley pericardial xenograft. J Thorac Cardiovasc Surg 1977; 73:31-42.
6. Aupecle B, Serraf A, Belli E, Mohammadi S, Lacour-Gayet F, Fornes P et al. Intermediate follow-up of a composite stentless porcine valved conduit of bovine pericardium in the pulmonary circulation. Ann Thorac Surg 2002; 74:127-32.
7. Grimm M, Eybl E, Grabenwoger M, Spreitzer H, Jager W, Grimm G et al. Glutaraldehyde affects biocompatibility of bioprosthetic heart valves. Surgery 1992;111:74-8.
8. Schmidt CE, Baier JM. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000;21:2215-31.
9. Di Eusanio M, Schepens MA. Left atrial thrombus on a Teflon patch for ASD closure. Eur J Cardiothorac Surg 2002;21:542.
10. Bennink GB, Hitchcock FJ, Molenschot M, Hutter P, Sreeram N. Aneurysmal pericardial patch producing right ventricular inflow obstruction. Ann Thorac Surg 2001;71:1346-7.
11. Walther T, Tsang VT, Deanfield JE, de Leval MR. Closure of recurrent VSD due to dehiscence of calcified patch. Eur J Cardiothorac Surg 2003;23: 246-7.
12. Neethling WM, Glancy R, Hodge AJ. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model. J Heart Valve Dis 2010;19:778-85.
13. Crawford FA Jr, Sade RM, Spinale F. Bovine pericardium for correction of congenital heart defects. Ann Thorac Surg 1986;41:602-5.
14. Pok S, Jacot JG. Biomaterials advances in patches for congenital heart defect repair. J Cardiovasc Transl Res 2011;4:646-54.
15. Marelli AJ, Gurvitz M. From numbers to guidelines. Prog Cardiovasc Dis 2011;53:239-46.
16. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007;115:163-72.
17. Gober V, Berdat P, Pavlovic M, Pfammatter JP, Carrel TP. Adverse mid-term outcome following RVOT reconstruction using the Contegra valved bovine jugular vein. Ann Thorac Surg 2005;79:625-31.
18. Pearl JM, Cooper DS, Bove KE, Manning PB. Early failure of the Shelhigh pulmonary valve conduit in infants. Ann Thorac Surg 2002;74:542-8; discussion 8-9.